1
|
O’Brien VP, Jackson LK, Frick JP, Rodriguez Martinez AE, Jones DS, Johnston CD, Salama NR. Helicobacter pylori Chronic Infection Selects for Effective Colonizers of Metaplastic Glands. mBio 2023; 14:e0311622. [PMID: 36598261 PMCID: PMC9973278 DOI: 10.1128/mbio.03116-22] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2022] [Accepted: 12/05/2022] [Indexed: 01/05/2023] Open
Abstract
Chronic gastric infection with Helicobacter pylori can lead to progressive tissue changes that culminate in cancer, but how H. pylori adapts to the changing tissue environment during disease development is not fully understood. In a transgenic mouse gastric metaplasia model, we found that strains from unrelated individuals differed in their ability to infect the stomach, to colonize metaplastic glands, and to alter the expression of the metaplasia-associated protein TFF3. H. pylori isolates from different stages of disease from a single individual had differential ability to colonize healthy and metaplastic gastric glands. Exposure to the metaplastic environment selected for high gastric colonization by one of these strains. Complete genome sequencing revealed a unique alteration in the frequency of a variant allele of the putative adhesin sabB, arising from a recombination event with the related sialic acid binding adhesin (SabA) gene. Mutation of sabB in multiple H. pylori strain backgrounds strongly reduced adherence to both normal and metaplastic gastric tissue, and highly attenuated stomach colonization in mice. Thus, the changing gastric environment during disease development promotes bacterial adhesin gene variation associated with enhanced gastric colonization. IMPORTANCE Chronic infection with Helicobacter pylori is the primary risk factor for developing stomach cancer. As disease progresses H. pylori must adapt to a changing host tissue environment that includes induction of new cell fates in the cells that line the stomach. We tested representative H. pylori isolates collected from the same patient during early and later stages of disease in a mouse model where we can rapidly induce disease-associated tissue changes. Only the later-stage H. pylori strains could robustly colonize the diseased stomach environment. We also found that the ability to colonize the diseased stomach was associated with genetic variation in a putative cell surface adhesin gene called sabB. Additional experiments revealed that SabB promotes binding to stomach tissue and is critical for stomach colonization by the late-stage strains. Thus, H. pylori diversifies its genome during disease progression and these genomic changes highlight critical factors for bacterial persistence.
Collapse
Affiliation(s)
- V. P. O’Brien
- Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA
| | - L. K. Jackson
- Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA
- Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, USA
| | - J. P. Frick
- Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA
- Department of Microbiology, University of Washington, Seattle, Washington, USA
| | | | - D. S. Jones
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA
| | - C. D. Johnston
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA
| | - N. R. Salama
- Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA
- Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, USA
- Department of Microbiology, University of Washington, Seattle, Washington, USA
| |
Collapse
|
2
|
Andrews GP, Li S, Almajaan A, Yu T, Martini L, Healy A, Jones DS. Fixed Dose Combination Formulations: Multilayered Platforms Designed for the Management of Cardiovascular Disease. Mol Pharm 2019; 16:1827-1838. [DOI: 10.1021/acs.molpharmaceut.8b01068] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- G. P. Andrews
- Pharmaceutical Engineering Group, School of Pharmacy, Queen’s University, Belfast BT9, U.K
| | - S. Li
- Pharmaceutical Engineering Group, School of Pharmacy, Queen’s University, Belfast BT9, U.K
| | - A. Almajaan
- Pharmaceutical Engineering Group, School of Pharmacy, Queen’s University, Belfast BT9, U.K
| | - T. Yu
- Pharmaceutical Engineering Group, School of Pharmacy, Queen’s University, Belfast BT9, U.K
| | - L. Martini
- Royal Pharmaceutical Society, East Smithfield, London E1W 1AW, U.K
| | - A. Healy
- School of Pharmacy and Pharmaceutical Sciences, Panoz Institute, Trinity College Dublin, Dublin 2, Ireland
| | - D. S. Jones
- Pharmaceutical Engineering Group, School of Pharmacy, Queen’s University, Belfast BT9, U.K
| |
Collapse
|
3
|
Kelleher JF, Gilvary GC, Madi AM, Jones DS, Li S, Tian Y, Almajaan A, Senta-Loys Z, Andrews GP, Healy AM. A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products. Int J Pharm 2018; 545:183-196. [PMID: 29730176 DOI: 10.1016/j.ijpharm.2018.05.008] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2018] [Revised: 04/30/2018] [Accepted: 05/02/2018] [Indexed: 11/26/2022]
Abstract
The purpose of this work was to investigate the application of different advanced continuous processing techniques (hot melt extrusion and spray drying) to the production of fixed-dose combination (FDC) monolithic systems comprising of hydrochlorothiazide and ramipril for the treatment of hypertension. Identical FDC formulations were manufactured by the two different methods and were characterised using powder X-ray diffraction (PXRD) and modulated differential scanning calorimetry (mDSC). Drug dissolution rates were investigated using a Wood's apparatus, while physical stability was assessed on storage under controlled temperature and humidity conditions. Interestingly both drugs were transformed into their amorphous forms when spray dried, however, hydrochlorothiazide was determined, by PXRD, to be partially crystalline when hot melt extruded with either polymer carrier (Kollidon® VA 64 or Soluplus®). Hot melt extrusion was found to result in significant degradation of ramipril, however, this could be mitigated by the inclusion of the plasticizer, polyethylene glycol 3350, in the formulation and appropriate adjustment of processing temperature. The results of intrinsic dissolution rate studies showed that hot-melt extruded samples were found to release both drugs faster than identical formulations produced via spray drying. However, the differences were attributable to the surface roughness of the compressed discs in the Wood's apparatus, rather than solid state differences between samples. After a 60-day stability study spray dried samples exhibited a greater physical stability than the equivalent hot melt extruded samples.
Collapse
Affiliation(s)
- J F Kelleher
- School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland
| | - G C Gilvary
- School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom
| | - A M Madi
- School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland
| | - D S Jones
- School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom
| | - S Li
- School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom
| | - Y Tian
- School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom
| | - A Almajaan
- School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom
| | - Z Senta-Loys
- School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom
| | - G P Andrews
- School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom
| | - A M Healy
- School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland.
| |
Collapse
|
4
|
Stevens EWN, Bailey JV, Flood BE, Jones DS, Gilhooly WP, Joye SB, Teske A, Mason OU. Barite encrustation of benthic sulfur-oxidizing bacteria at a marine cold seep. Geobiology 2015; 13:588-603. [PMID: 26462132 DOI: 10.1111/gbi.12154] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/05/2015] [Accepted: 07/18/2015] [Indexed: 06/05/2023]
Abstract
Crusts and chimneys composed of authigenic barite are found at methane seeps and hydrothermal vents that expel fluids rich in barium. Microbial processes have not previously been associated with barite precipitation in marine cold seep settings. Here, we report on the precipitation of barite on filaments of sulfide-oxidizing bacteria at a brine seep in the Gulf of Mexico. Barite-mineralized bacterial filaments in the interiors of authigenic barite crusts resemble filamentous sulfide-oxidizing bacteria of the genus Beggiatoa. Clone library and iTag amplicon sequencing of the 16S rRNA gene show that the barite crusts that host these filaments also preserve DNA of Candidatus Maribeggiatoa, as well as sulfate-reducing bacteria. Isotopic analyses show that the sulfur and oxygen isotope compositions of barite have lower δ(34)S and δ(18)O values than many other marine barite crusts, which is consistent with barite precipitation in an environment in which sulfide oxidation was occurring. Laboratory experiments employing isolates of sulfide-oxidizing bacteria from Gulf of Mexico seep sediments showed that under low sulfate conditions, such as those encountered in brine fluids, sulfate generated by sulfide-oxidizing bacteria fosters rapid barite precipitation localized on cell biomass, leading to the encrustation of bacteria in a manner reminiscent of our observations of barite-mineralized Beggiatoa in the Gulf of Mexico. The precipitation of barite directly on filaments of sulfide-oxidizing bacteria, and not on other benthic substrates, suggests that sulfide oxidation plays a role in barite formation at certain marine brine seeps where sulfide is oxidized to sulfate in contact with barium-rich fluids, either prior to, or during, the mixing of those fluids with sulfate-containing seawater in the vicinity of the sediment/water interface. As with many other geochemical interfaces that foster mineral precipitation, both biological and abiological processes likely contribute to the precipitation of barite at marine brine seeps such as the one studied here.
Collapse
Affiliation(s)
- E W N Stevens
- Department of Earth Sciences, University of Minnesota-Twin Cities, Minneapolis, MN, USA
| | - J V Bailey
- Department of Earth Sciences, University of Minnesota-Twin Cities, Minneapolis, MN, USA
| | - B E Flood
- Department of Earth Sciences, University of Minnesota-Twin Cities, Minneapolis, MN, USA
| | - D S Jones
- Department of Earth Sciences, University of Minnesota-Twin Cities, Minneapolis, MN, USA
| | - W P Gilhooly
- Department of Earth Sciences, Indiana University-Purdue University Indianapolis, Indianapolis, IN, USA
| | - S B Joye
- Department of Marine Sciences, University of Georgia, Athens, GA, USA
| | - A Teske
- Department of Marine Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - O U Mason
- Earth, Ocean, and Atmospheric Science, Florida State University, Tallahassee, FL, USA
| |
Collapse
|
5
|
Laverty G, Gilmore BF, Jones DS, Coyle L, Folan M, Breathnach R. Antimicrobial efficacy of an innovative emulsion of medium chain triglycerides against canine and feline periodontopathogens. J Small Anim Pract 2015; 56:253-63. [PMID: 25728584 DOI: 10.1111/jsap.12344] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2014] [Revised: 10/29/2014] [Accepted: 12/02/2014] [Indexed: 11/30/2022]
Abstract
OBJECTIVES To test the in vitro antimicrobial efficacy of a non-toxic emulsion of free fatty acids against clinically relevant canine and feline periodontopathogens METHODS Antimicrobial kill kinetics were established utilising an alamarBlue(®) viability assay against 10 species of canine and feline periodontopathogens in the biofilm mode of growth at a concentration of 0·125% v/v medium chain triglyceride (ML:8) emulsion. The results were compared with 0·12% v/v chlorhexidine digluconate and a xylitol-containing dental formulation. Mammalian cellular cytotoxicity was also investigated for both the ML:8 emulsion and chlorhexidine digluconate (0·25 to 0·0625% v/v) using in vitro tissue culture techniques. RESULTS No statistically significant difference was observed in the antimicrobial activity of the ML:8 emulsion and chlorhexidine digluconate; a high percentage kill rate (>70%) was achieved within 5 minutes of exposure and was maintained at subsequent time points. A statistically significant improvement in antibiofilm activity was observed with the ML:8 emulsion compared with the xylitol-containing formulation. The ML:8 emulsion possessed a significantly lower (P < 0·001) toxicity profile compared with the chlorhexidine digluconate in mammalian cellular cytotoxicity assays. CLINICAL SIGNIFICANCE The ML:8 emulsion exhibited significant potential as a putative effective antimicrobial alternative to chlorhexidine- and xylitol- based products for the reduction of canine and feline periodontopathogens.
Collapse
Affiliation(s)
- G Laverty
- Ward Research & Development Ltd., Glasdrumman, Milltown, Monaghan, Ireland; Biomaterials, Biofilm and Infection Control Research Group, School of Pharmacy, Queens University Belfast, Belfast BT9 7BL
| | | | | | | | | | | |
Collapse
|
6
|
Zhai H, Jones DS, McCoy CP, Madi AM, Tian Y, Andrews GP. Gastroretentive extended-release floating granules prepared using a novel fluidized hot melt granulation (FHMG) technique. Mol Pharm 2014; 11:3471-83. [PMID: 25105340 DOI: 10.1021/mp500242q] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
The objective of this work was to investigate the feasibility of using a novel granulation technique, namely, fluidized hot melt granulation (FHMG), to prepare gastroretentive extended-release floating granules. In this study we have utilized FHMG, a solvent free process in which granulation is achieved with the aid of low melting point materials, using Compritol 888 ATO and Gelucire 50/13 as meltable binders, in place of conventional liquid binders. The physicochemical properties, morphology, floating properties, and drug release of the manufactured granules were investigated. Granules prepared by this method were spherical in shape and showed good flowability. The floating granules exhibited sustained release exceeding 10 h. Granule buoyancy (floating time and strength) and drug release properties were significantly influenced by formulation variables such as excipient type and concentration, and the physical characteristics (particle size, hydrophilicity) of the excipients. Drug release rate was increased by increasing the concentration of hydroxypropyl cellulose (HPC) and Gelucire 50/13, or by decreasing the particle size of HPC. Floating strength was improved through the incorporation of sodium bicarbonate and citric acid. Furthermore, floating strength was influenced by the concentration of HPC within the formulation. Granules prepared in this way show good physical characteristics, floating ability, and drug release properties when placed in simulated gastric fluid. Moreover, the drug release and floating properties can be controlled by modification of the ratio or physical characteristics of the excipients used in the formulation.
Collapse
Affiliation(s)
- H Zhai
- The Drug Delivery and Biomaterials Group, School of Pharmacy, Medical Biology Centre, Queen's University Belfast , 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, U.K
| | | | | | | | | | | |
Collapse
|
7
|
Quinten T, Andrews GP, De Beer T, Saerens L, Bouquet W, Jones DS, Hornsby P, Remon JP, Vervaet C. Preparation and evaluation of sustained-release matrix tablets based on metoprolol and an acrylic carrier using injection moulding. AAPS PharmSciTech 2012; 13:1197-211. [PMID: 22965662 DOI: 10.1208/s12249-012-9848-6] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2012] [Accepted: 08/22/2012] [Indexed: 11/30/2022] Open
Abstract
Sustained-release matrix tablets based on Eudragit RL and RS were manufactured by injection moulding. The influence of process temperature; matrix composition; drug load, plasticizer level; and salt form of metoprolol: tartrate (MPT), fumarate (MPF) and succinate (MPS) on ease of processing and drug release were evaluated. Formulations composed of 70/30% Eudragit RL/MPT showed the fastest drug release, substituting part of Eudragit RL by RS resulted in slower drug release, all following first-order release kinetics. Drug load only affected drug release of matrices composed of Eudragit RS: a higher MPT concentration yielded faster release rates. Adding triethyl citrate enhanced the processability, but was detrimental to long-term stability. The process temperature and plasticizer level had no effect on drug release, whereas metoprolol salt form significantly influenced release properties. The moulded tablets had a low porosity and a smooth surface morphology. A plasticizing effect of MPT, MPS and MPF on Eudragit RS and Eudragit RL was observed via DSC and DMA. Solubility parameter assessment, thermal analysis and X-ray diffraction demonstrated the formation of a solid solution immediately after production, in which H-bonds were formed between metoprolol and Eudragit as evidenced by near-infrared spectroscopy. However, high drug loadings of MPS and MPF showed a tendency to recrystallise during storage. The in vivo performance of injection-moulded tablets was strongly dependent upon drug loading.
Collapse
|
8
|
|
9
|
Djokic J, Jones DS, Gorman SP. Development of a novel polymer coating for urinary medical devices: Assessment of biodegradation and resistance to encrustation. J Pharm Pharmacol 2011. [DOI: 10.1111/j.2042-7158.1998.tb02372.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- J Djokic
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - D S Jones
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - S P Gorman
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| |
Collapse
|
10
|
Affiliation(s)
- A F Brown
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - D S Jones
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - A D Woolfson
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| |
Collapse
|
11
|
Affiliation(s)
- C P Garvin
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - D S Jones
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - S P Gorman
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - F Quigley
- Boston Scientific Corporation, Galway, Ireland
| |
Collapse
|
12
|
Affiliation(s)
- L G Hare
- Biomedical and Environmental Sensor Technology Centre, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - D S Jones
- Biomedical and Environmental Sensor Technology Centre, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - A D Woolfson
- Biomedical and Environmental Sensor Technology Centre, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| |
Collapse
|
13
|
Affiliation(s)
- D S Jones
- Department of Pharmacy, The Queen's University of Belfast, Belfast BT9 7BL. (UK)
| | - S P Gorman
- Department of Pharmacy, The Queen's University of Belfast, Belfast BT9 7BL. (UK)
| | - D F McCafferty
- Department of Pharmacy, The Queen's University of Belfast, Belfast BT9 7BL. (UK)
| | - A D Woolfson
- Department of Pharmacy, The Queen's University of Belfast, Belfast BT9 7BL. (UK)
| |
Collapse
|
14
|
McGovern JG, Jones DS, Gorman SP. The influence of a non-ionic surfactant on the adherence of Candida albicans to human buccal epithelial cells. J Pharm Pharmacol 2011. [DOI: 10.1111/j.2042-7158.1998.tb02334.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- J G McGovern
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - D S Jones
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - S P Gorman
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| |
Collapse
|
15
|
Mccrystal CB, Fee JPH, Renfrew CW, Murray JM, Jones DS. In-vitro characterization of novel carbon dioxide absorbents for use in anaesthetic breathing systems. J Pharm Pharmacol 2011. [DOI: 10.1111/j.2042-7158.1998.tb02387.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- C B Mccrystal
- School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - J P H Fee
- Department of Anaesthetics, The Queen’s University of Belfast, Belfast
| | - C W Renfrew
- Department of Anaesthetics, The Queen’s University of Belfast, Belfast
| | - J M Murray
- Department of Anaesthetics, The Queen’s University of Belfast, Belfast
| | - D S Jones
- School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| |
Collapse
|
16
|
Mcgovern JG, Jones DS, Gorman SP. Physical characterization of non-aqueous gels incorporating tetracycline hydrochloride for treatment of periodontitis. J Pharm Pharmacol 2011. [DOI: 10.1111/j.2042-7158.1998.tb02340.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- J G Mcgovern
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - D S Jones
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - S P Gorman
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| |
Collapse
|
17
|
Affiliation(s)
- M S Lawlor
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - D S Jones
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - A D Woolfson
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| |
Collapse
|
18
|
Brown AF, Jones DS, Woolfson AD. Thermorheology of polaxamer 407: Effect of alcohols and drugs. J Pharm Pharmacol 2011. [DOI: 10.1111/j.2042-7158.1998.tb02359.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- A F Brown
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - D S Jones
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - A D Woolfson
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| |
Collapse
|
19
|
Byers LM, Adair CG, Gorman SP, Jones DS, Goldsmith CE. The role of microbial biofilm in ventilator-associated pneumonia. J Pharm Pharmacol 2011. [DOI: 10.1111/j.2042-7158.1998.tb02241.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- L M Byers
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - C G Adair
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - S P Gorman
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - D S Jones
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - C E Goldsmith
- Department of Bacteriology, Belfast City Hospital, Lisburn Road, Belfast
| |
Collapse
|
20
|
Jones DS, Medlicott NJ, Rathbone MJ, Holborow D, Tucker IG. Controlled localized delivery of chlorhexidine for inhibition of plaque formation. J Pharm Pharmacol 2011. [DOI: 10.1111/j.2042-7158.1998.tb02356.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- D S Jones
- School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast
| | - N J Medlicott
- School of Pharmacy, University of Otago, Dunedin, New Zealand
| | - M J Rathbone
- School of Pharmacy, University of Otago, Dunedin, New Zealand
| | - D Holborow
- School of Pharmacy, University of Otago, Dunedin, New Zealand
| | - I G Tucker
- School of Pharmacy, University of Otago, Dunedin, New Zealand
| |
Collapse
|
21
|
Djokic J, Mcelhatton A, Jones DS, Gorman SP. The effect of Betadine on Candida albicans virulence factors. J Pharm Pharmacol 2011. [DOI: 10.1111/j.2042-7158.1998.tb02331.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- J Djokic
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - A Mcelhatton
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - D S Jones
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - S P Gorman
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| |
Collapse
|
22
|
Hare LG, Jones DS, Woolfson AD. Rheological analysis of carbopol/hydroxyethylcellulose gels as platforms for topical drug delivery. J Pharm Pharmacol 2011. [DOI: 10.1111/j.2042-7158.1998.tb02446.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- L G Hare
- Biomedical and Environmental Sensor Technology Centre, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - D S Jones
- Biomedical and Environmental Sensor Technology Centre, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - A D Woolfson
- Biomedical and Environmental Sensor Technology Centre, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| |
Collapse
|
23
|
Garvin CP, Jones DS, Gorman SP. Development of a lubricity test for urinary biomaterials. J Pharm Pharmacol 2011. [DOI: 10.1111/j.2042-7158.1998.tb02363.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- C P Garvin
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - D S Jones
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - S P Gorman
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| |
Collapse
|
24
|
Affiliation(s)
- A F Brown
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - D S Jones
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| | - A D Woolfson
- Pharmaceutical Devices Group, School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL
| |
Collapse
|
25
|
Brown AF, Jones DS, Woolfson AD, Bell SEJ, Dennis AC, Matchett LJ. Investigation of a drug-polymer interaction using Raman spectroscopy. J Pharm Pharmacol 2011. [DOI: 10.1111/j.2042-7158.1998.tb02289.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- A F Brown
- School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast
| | - D S Jones
- School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast
| | - A D Woolfson
- School of Pharmacy, The Queen’s University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast
| | - S E J Bell
- School of Chemistry, The Queen’s University of Belfast, Stranmillis Road, Belfast
| | - A C Dennis
- School of Chemistry, The Queen’s University of Belfast, Stranmillis Road, Belfast
| | - L J Matchett
- School of Chemistry, The Queen’s University of Belfast, Stranmillis Road, Belfast
| |
Collapse
|
26
|
Shaffer KN, Jones DS. Effect of tobramycin, amiloride and sodium deoxycholate on the in vitro activity of ciprofloxacin against Pseudomonas aeruginosa. International Journal of Pharmacy Practice 2011. [DOI: 10.1111/j.2042-7174.1993.tb00713.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Abstract
The effects of sodium deoxycholate, tobramycin and amiloride on the inhibitory effect (minimum inhibitory concentration) of ciprofloxacin against Pseudomonas aeruginosa (strain PAO 511 and two clinical isolates, one from a burn infection and the other from a cystic fibrosis respiratory tract infection) were examined in vitro. The method used was a macrodilution technique in Mueller-Hinton broth at 37C. Marked enhancement of ciprofloxacin activity was observed in the presence of 4.15mg/ml sodium deoxycholate, 0.4μg/ml tobramycin and 50μg/ml amiloride. It is suggested that these observations may be clinically important in the treatment of localised Pseudomonas aeruginosa infections, eg, within the respiratory tract of cystic fibrosis patients.
Collapse
Affiliation(s)
- K N Shaffer
- School of Pharmacy, University of Otago, New Zealand
| | - D S Jones
- School of Pharmacy, University of Otago, New Zealand
| |
Collapse
|
27
|
Macdonald FA, Schmitz MD, Crowley JL, Roots CF, Jones DS, Maloof AC, Strauss JV, Cohen PA, Johnston DT, Schrag DP. Calibrating the Cryogenian. Science 2010; 327:1241-3. [DOI: 10.1126/science.1183325] [Citation(s) in RCA: 419] [Impact Index Per Article: 29.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
28
|
Jia L, Gu Y, Zeng E, Linnik MD, Jones DS. Pharmacokinetics of LJP 993, a tetrameric conjugate of domain 1 of beta2-glycoprotein I for antiphospholipid syndrome. Lupus 2009; 19:130-7. [PMID: 19919973 DOI: 10.1177/0961203309348982] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
beta2-glycoprotein I is the best-characterized antigenic target for antiphospholipid autoantibodies. We synthesized a tetrameric conjugate of the domain 1 of beta2-glycoprotein I (LJP 993) aimed at developing the conjugate as a Toleragen to suppress antiphospholipid syndrome. The present studies focused on determining the stability, tissue distribution, plasma concentration-time profile and excretion of the LJP 993 in mice. The stability of LJP 993 in mouse plasma was quantitatively evaluated using strong cation-exchange high performance liquid chromatography. ( 125)I-labeled LJP 993 was intravenously injected to mice, and levels of (125)I-labeled LJP 993 in plasma, tissues, urine and feces were determined at known intervals. Incubation of LJP 993 with mouse serum at 37 degrees C for 8 h resulted in a decrease by 34% of LJP 993 concentration. No degradation fragment was observed during the incubation. After a single intravenous administration of (125)I-LJP 993 (0.5 and 5 mg/kg) to mice, both C(max) and area-under-curve values increased in a dose-proportional manner, and blood radioactivity disappeared in a bi-exponential manner with the distribution half-lives equal to 1.7 min, and the elimination half-lives 188 and 281 min, respectively. The (125)I-LJP 993 was moderately distributed into organs and tissues with the exception that brain level of ( 125)I-LJP 993 was negligible. The major sites of (125)I-LJP 993 uptake were the kidney (at 30 min post dosing), and kidney, lung, liver, heart, spleen, skin, muscle and fat tissues (at 4 h post dosing). Cumulative urinary and fecal radioactivity for 0-48 h post dosing accounted for 44.7% and 4.2% of the administered dose, respectively, with the fast rate of urinal excretion occurring within the first 8 h. In summary, LJP 993 was fairly stable in mouse plasma. After administration to mice, (125)I-LJP 993 was taken up mainly by kidney and then distributed extensively to tissues except brain. Both C(max) and area-under-curve values increased in a dose-proportional manner. It was predominantly excreted in the urine with an elimination half-life longer than 3 h. Kidney is a major route to excrete the tetrameric conjugate.
Collapse
Affiliation(s)
- L Jia
- La Jolla Pharmaceutical Company, San Diego CA, USA.
| | | | | | | | | |
Collapse
|
29
|
O'Rourke AM, Wang EY, Salter-Cid L, Huang L, Miller A, Podar E, Gao HF, Jones DS, Linnik MD. Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis. J Neural Transm (Vienna) 2007; 114:845-9. [PMID: 17393060 DOI: 10.1007/s00702-007-0699-3] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2006] [Accepted: 10/26/2006] [Indexed: 11/28/2022]
Abstract
We have developed several series of potent and selective small molecule inhibitors of SSAO (AOC3/VAP-1) that also block trafficking of leukocytes to sites of inflammation. Blocking of SSAO-mediated leukocyte adhesion has recently been shown efficacious in several models of inflammatory diseases. We have examined the potential of SSAO inhibitors in neurological diseases, having previously demonstrated the efficacy of SSAO inhibition in a rat model of stroke. Here we show the effect of the small molecule SSAO inhibitor LJP 1207 (IC(50) human SSAO 17 nM; ratio IC(50) SSAO:MAO >5000), on relapsing-remitting experimental autoimmune encephalomyelitis (EAE), a mouse model that shares many characteristics with human multiple sclerosis. Clinical efficacy was observed when dosing with LJP 1207 was initiated either at the peak of initial flare or during remission. These data demonstrate the potential clinical benefit of small molecule anti-SSAO therapy in this model.
Collapse
Affiliation(s)
- A M O'Rourke
- La Jolla Pharmaceutical Company, San Diego, CA 92121, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Malcolm RK, McCullagh SD, Woolfson AD, Gorman SP, Jones DS, Cuddy J. Controlled release of a model antibacterial drug from a novel self-lubricating silicone biomaterial. J Control Release 2004; 97:313-20. [PMID: 15196758 DOI: 10.1016/j.jconrel.2004.03.029] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2004] [Accepted: 03/30/2004] [Indexed: 10/26/2022]
Abstract
There is considerable interest in developing medical devices that provide controlled delivery of biologically active agents, for example, to reduce the incidence of device-related infection. Silicone elastomers are one of the commonest biomaterials used in medical device production. However, they have a relatively high coefficient of friction and the resulting lack of lubricity can cause pain and tissue damage on device insertion and removal. Novel silicone cross-linking agents have recently been reported that produce inherently 'self-lubricating' silicone elastomers with very low coefficients of friction. In this study, the model antibacterial drug metronidazole has been incorporated into these self-lubricating silicone elastomers to produce a novel bioactive biomaterial. The in vitro release characteristics of the bioactive component were evaluated as a function of cross-linker composition and drug loading. Although conventional matrix-type release kinetics were observed for metronidazole from the silicone systems, it was also observed that increasing the concentration of the cross-linking agent responsible for the lubricious character (tetra(oleyloxy)silane) relative to that of the standard non-lubricious cross-linking agent (tetrapropoxysilane) produced an increase in the metronidazole flux rate by up to 65% for a specified drug loading. The results highlight the potential for developing lubricious silicone medical devices with enhanced drug release characteristics.
Collapse
Affiliation(s)
- R K Malcolm
- School of Pharmacy, The Queen's University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, UK
| | | | | | | | | | | |
Collapse
|
31
|
Long CP, McCafferty DF, Sittlington NM, Halliday HL, Woolfson AD, Jones DS. Randomized trial of novel tetracaine patch to provide local anaesthesia in neonates undergoing venepuncture. Br J Anaesth 2003; 91:514-8. [PMID: 14504152 DOI: 10.1093/bja/aeg216] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Procedures such as venepuncture or heel prick are painful and may cause considerable stress to newborn infants. Topical local anaesthetics are effective for venepuncture but need to be applied for at least 60 min and the delivered dose will vary. We assessed a novel tetracaine-based self-adhesive patch in providing controlled local anaesthesia before venepuncture. METHODS A placebo-controlled, double-blind trial was conducted using a tetracaine patch formulated from hydroxypropylcellulose discs (0.283 cm(2)) containing tetracaine (1 mg x cm(-2)) surrounded by a low tack pressure-sensitive adhesive backing layer. Thirty-two newborn infants of gestation 32-42 weeks (median 36 weeks), aged 3-18 days (median 6 days) were randomized to receive a tetracaine-containing patch or a placebo device applied to the dorsum of the hand 30 min before venepuncture to obtain blood samples. Pain was assessed in response to needle insertion using a validated adaptation of the neonatal facial coding score (NFCS) and the presence of crying. RESULTS Of 15 tetracaine-treated neonates, 14 (93%) presented little or no pain in response to the procedure compared with six of 17 (35%) who had the placebo patch applied (P=0.01). CONCLUSIONS The tetracaine patch produced effective pain relief during the venepuncture procedure in both term and pre-term infants. There were no adverse effects, either local or systemic.
Collapse
Affiliation(s)
- C P Long
- School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK.
| | | | | | | | | | | |
Collapse
|
32
|
|
33
|
Adair CG, Gorman SP, Byers LM, Jones DS, Feron B, Crowe M, Webb HC, McCarthy GJ, Milligan KR. Eradication of endotracheal tube biofilm by nebulised gentamicin. Intensive Care Med 2002; 28:426-31. [PMID: 11967596 DOI: 10.1007/s00134-002-1223-8] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2001] [Accepted: 12/19/2001] [Indexed: 11/24/2022]
Abstract
OBJECTIVE To compare the efficacy of gentamicin, nebulised via the endotracheal tube (ET), with that of parenteral cefotaxime or parenteral cefuroxime in preventing the formation of ET biofilm. SETTING General intensive care units in two university teaching hospitals. DESIGN The microbiology of ET biofilm from 36 ICU patients eligible to receive antibiotic prophylaxis was examined. Peak and trough tracheal concentrations of gentamicin, cefotaxime or cefuroxime were measured in each patient group, on the 2nd day of intubation. PATIENTS Twelve patients received gentamicin (80 mg) nebulised in 4 ml normal saline every 8 h, 12 cefotaxime (1 g, 12 hourly) and 12 cefuroxime (750 mg, 8 hourly). Prophylaxis was continued for the duration of intubation. MEASUREMENTS AND RESULTS Samples of tracheal secretions were taken on the 2nd day of ventilation for determination of antibiotic concentrations. Following extubation, ETs were examined for the presence of biofilm. Pathogens considered to be common aetiological agents for VAP included Staphylococcus aureus, enterococci, Enterobacteriaceae and pseudomonads. While microbial biofilm was found on all ETs from the cephalosporin group, microbial biofilm of these micro-organisms was found on 7 of the 12 ET tubes from patients receiving cefotaxime [ S. aureus (4), pseudomonads (1), Enterobacteriaceae (1), enterococcus (1)] and 8 of the 12 ET tubes from patients receiving cefuroxime [Enterobacteriaceae (6), P. aeruginosa (1) and enterococcus (1)]. While microbial biofilm was observed on five ETs from patients receiving nebulised gentamicin, none of these were from pathogens for ventilator-associated pneumonia (VAP). Tracheal concentrations of both cephalosporins were lower than those needed to inhibit the growth of pathogens recovered from ET tube biofilm. The median (and range) concentrations for cefotaxime were 0.90 (<0.23-1.31) mg/l and 0.28 (<0.23-0.58) mg/l for 2 h post-dose and trough samples, respectively. Two hours post-dose concentrations of cefuroxime (median and range) were 0.40 (0.34-0.83) mg/l, with trough concentrations of 0.35 (<0.22-0.47) mg/l. Tracheal concentrations (median and range) of gentamicin measured 1 h post-nebulisation were 790 (352-->1250) mg/l and then, before the next dose, were 436 (250-1000) mg/l. CONCLUSION Nebulised gentamicin attained high concentrations in the ET lumen and was more effective in preventing the formation of biofilm than either parenterally administered cephalosporin and therefore may be effective in preventing this complication of mechanical ventilation.
Collapse
Affiliation(s)
- C G Adair
- School of Pharmacy, The Queen's University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Jones DS, Brown AF, Woolfson AD. Rheological characterization of bioadhesive, antimicrobial, semisolids designed for the treatment of periodontal diseases: transient and dynamic viscoelastic and continuous shear analysis. J Pharm Sci 2001; 90:1978-90. [PMID: 11745757 DOI: 10.1002/jps.1149] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
This study examined the creep behavior and oscillatory and flow properties of tetracycline-containing, bioadhesive semisolid formulations, designed for localized treatment of periodontal disease. Formulations were prepared containing hydroxyethylcellulose (HEC, 1, 3, or 5% w/w), poly(vinylpyrrolidone) (PVP, 2 or 3% w/w), polycarbophil (PC, 1 or 3% w/w), and tetracycline (5% w/w, as the hydrochloride). In creep analysis, each formulation exhibited several distinct regions that were mathematically modelled using a multi-element Voigt model with a residual spring and dashpot. Increasing the concentrations of each polymeric component decreased the elastic compliance (J(0)) yet increased the residual viscosity. In oscillatory analysis, increased polymer concentrations increased the storage modulus (G'), the loss modulus (G") and the dynamic viscosity (eta'), yet decreased the loss tangent (tan delta). The relationships between G' or G" and frequency were observed to plateau at higher frequencies, which is indicative of polymer chain entanglement and network formation. With the exception of formulations containing 1% HEC, the formulations were elastic (tan delta < 1), with large G' and small J(0) values. All formulations exhibited pseudoplastic flow with thixotropy. Increasing concentrations of each polymeric component increased the zero-shear viscosity (determined using the Cross model) and was further evidence of polymer chain entanglement. Formulations containing 1% w/w HEC possessed excellent flow properties, however, their thixotropic behavior and essentially elastoviscous nature (large J(0) and tan delta) would be disadvantageous for use in the treatment of periodontal disease because of rapid removal from the pocket and relatively uncontrolled drug release. Despite their advantageous viscoelastic properties, the flow properties of formulations containing 5% w/w HEC were inappropriate, rendering administration through a periodontal syringe potentially difficult. Based on their rheological behavior, formulations containing HEC (3% w/w), PVP (2 or 3% w/w), and PC (1 or 3% w/w) would be suitable for clinical application. However, consideration of other physicochemical properties (e.g., bioadhesion, drug release kinetics) must be performed prior to selection of the most suitable formulation for clinical examination. This study has highlighted the successful complimentary application of creep analysis and oscillatory and flow rheometry for the characterization and development of bioadhesive semisolid formulations for the treatment of periodontal disease.
Collapse
Affiliation(s)
- D S Jones
- School of Pharmacy, The Queen's University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, United Kingdom.
| | | | | |
Collapse
|
35
|
Jones DS, Cockerill KA, Gamino CA, Hammaker JR, Hayag MS, Iverson GM, Linnik MD, McNeeley PA, Tedder ME, Ton-Nu HT, Victoria EJ. Synthesis of LJP 993, a multivalent conjugate of the N-terminal domain of beta2GPI and suppression of an anti-beta2GPI immune response. Bioconjug Chem 2001; 12:1012-20. [PMID: 11716694 DOI: 10.1021/bc015512x] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
LJP 993, a tetravalent conjugate of the amino-terminal domain (domain 1) of beta2GPI, was synthesized, and studies were carried out to explore the ability of LJP 993 to bind anti-beta2GPI antibodies and to function as a B cell toleragen. Domain 1 was expressed in Pichia pastoris, and the N-terminus was site-specifically modified by a transamination reaction converting the N-terminal glycine to a glyoxyl group. A tetravalent platform was synthesized with linkers that terminate in aminooxy groups. This was accomplished by preparing an ethylene glycol-based heterobifunctional linker that contains both a Boc-protected aminooxy group and a free primary amine. The linker was used to modify a tetravalent platform molecule by reacting the amino groups on the linker with 4-nitrophenyl carbonate esters on the platform to provide a linker-modified platform, and the Boc protecting groups were removed to provide a tetravalent aminooxy platform. Glyoxylated domain 1 was attached to the platform to provide LJP 993 by formation of oxime bonds. The protein domains of LJP 993 retain activity as evidenced by the ability of LJP 993 to bind to anti-beta2GPI antibodies. Dissociation constants (Kd) for domain 1 and LJP 993 bound to immobilized affinity-purified anti-beta2GPI antibodies from autoimmune thrombosis patients were determined using surface plasmon resonance. An immunized mouse model was developed to test the ability of LJP 993 to act as a toleragen. A thiol containing domain 1 analogue was expressed in insect cells using the baculovirus expression system, and it was used to prepare an immunogenic conjugate of domain 1 and maleimide-derivatized keyhole limpet hemocyanin (KLH). Mice were immunized with the KLH conjugate, and spleen cells were harvested from the immunized mice. The cells were incubated with various concentrations of LJP 993 and transferred to mice whose immune systems had been compromised by irradiation. The hosts were then boosted with the KLH-domain 1 conjugate, and after 7 days their antibody levels were measured. Host mice receiving cells that were treated with LJP 993 produced significantly lower amounts of anti-domain 1 antibodies than controls which received untreated cells, indicative of B cell tolerance.
Collapse
Affiliation(s)
- D S Jones
- La Jolla Pharmaceutical Company, 6455 Nancy Ridge Drive, San Diego, California 92121, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Gorman SP, McGovern JG, Woolfson AD, Adair CG, Jones DS. The concomitant development of poly(vinyl chloride)-related biofilm and antimicrobial resistance in relation to ventilator-associated pneumonia. Biomaterials 2001; 22:2741-7. [PMID: 11545308 DOI: 10.1016/s0142-9612(01)00017-5] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Ventilator-associated pneumonia is a major cause of death in intensive care patients and the endotracheal tube, commonly fabricated from poly(vinyl chloride) (PVC), is acknowledged as a significant factor in this. Bacteria colonise the biomaterial, thereby adopting a sessile mode of growth that progresses to the establishment of an antibiotic-resistant biofilm by the accretion of a protective glycocalyx. This study examined the sequential steps involved in the formation of biofilm on PVC by atomic force microscopy and the concomitant development of resistance to an antibiotic (ceftazidime) and to a non-antibiotic antimicrobial agent (hexetidine). Staphylococcus aureus and Pseudomonas aeruginosa isolated from ET tube biofilm were employed. The surface microrugosity of bacteria growing in sessile mode on PVC decreased significantly (p < 0.05) over the period 4, 24, 48 h and 5 d. The progressive accretion of bacterial glycocalyx was readily visualised in micrographs leading to a smoother surface topography with time. The minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) for ceftazidime and hexetidine against planktonic (suspension) S. aureus were lower than for Ps. aeruginosa. Furthermore, sessile populations of S. aureus and Ps. aeruginosa on PVC exhibited greater resistance to both ceftazidime and hexetidine when compared to planktonic bacterial growth. The efficacy of the agents, determined by kill kinetics, against sessile bacteria was dependent on age, with established biofilms (> or = 24 h) significantly more resistant (p < 0.05) than early sessile populations (< or = 4 h). Importantly, for practice, even newly colonised bacteria (1 h) were significantly more resistant to antibiotic than planktonic bacteria. Hexetidine was significantly more active (p < 0.05) than ceftazidime on biofilms of both isolates, irrespective of age, with total kill within 24 h treatment. Hexetidine may offer promise in the resolution of infection associated with PVC endotracheal tubes.
Collapse
Affiliation(s)
- S P Gorman
- Medical Devices Group, School of Pharmacy, Medical Biology Centre, The Queen's University of Belfast, UK.
| | | | | | | | | |
Collapse
|
37
|
Holmwood C, Jones DS, Jackson-Bowers E. The depression puzzle. Do the pieces fit? Aust Fam Physician 2001; 30:489-92. [PMID: 11432023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
Abstract
BACKGROUND Depression is a common problem in the Australian community. It results in considerable disability. Currently screening tools promoted for detection of depression are nonspecific. They are not diagnostic tools. While people identified by screening are, by definition, at higher risk of depression, the diagnosis still needs to be based on interview findings. Screening tools do not substitute for time spent with patients developing rapport and an understanding of the causes of the depression and formulating possible management steps. Screening alone has not been shown to improve outcomes for people with depression. OBJECTIVE This article examines the current prevalence of depression in Australia and whether screening tools ultimately contribute to a reduction in morbidity. DISCUSSION Screening instruments have arbitrary cut off points for identifying patients with depression and their findings regarding prevalence should be applied with caution. If the thresholds are low then 'prevalences' are raised. It is unclear whether all 'cases' detected using screening instruments require clinical intervention.
Collapse
Affiliation(s)
- C Holmwood
- Primary Mental Health Care Australian Resource Centre, Department of General Practice, Flinders University, South Australia
| | | | | |
Collapse
|
38
|
Jones DS, McGovern JG, Adair CG, Woolfson AD, Gorman SP. Conditioning film and environmental effects on the adherence of Candida spp. to silicone and poly(vinylchloride) biomaterials. J Mater Sci Mater Med 2001; 12:399-405. [PMID: 15348278 DOI: 10.1023/a:1011240818338] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
The reported incidence of colonization of oropharyngeal medical devices with Candida spp. has increased in recent years, although few studies that have systematically examined the adherence of yeast cells to such biomaterials, the primary step in the process of colonization. This study, therefore, examined the effects of oropharyngeal atmospheric conditions (5% v/v carbon dioxide) and the presence of a salivary conditioning film on both the surface properties and adherence of Candida albicans, Candida krusei and Candida tropicalis to PVC and silicone. Furthermore, the effects of the salivary conditioning film on the surface properties of these biomaterials are reported. Growth of the three Candida spp. in an atmosphere containing 5% v/v CO2 significantly increased their cell surface hydrophobicity and reduced the zeta potential of C. albicans and C. krusei yet increased the zeta potential of C. tropicalis (p<0.05). Furthermore, growth in 5% v/v CO2 decreased the adherence of C. tropicalis and C. albicans to both PVC and silicone, however, increased adherence of C. krusei (p<0.05). Pre-treatment of the microorganisms with pooled human saliva significantly decreased their cell surface hydrophobicity and increased their adherence to either biomaterial in comparison to yeast cells that had been pre-treated with PBS (p<0.05). Saliva treatment of the microorganisms had no consistent effect on microbial zeta potential. Interestingly, adherence of the three, saliva-treated Candida spp. to saliva-treated silicone and PVC was significantly lower than whenever the microorganisms and biomaterials had been treated with PBS (p<0.05). Treatment of silicone and PVC with saliva significantly altered the surface properties, notably reducing both the advancing and receding contact angles and, additionally, the microrugosity. These effects may contribute to the decreased adherence of saliva-treated microorganisms to these biomaterials. In conclusion, this study has demonstrated the effects of physiological conditions within the oral cavity on the adherence of selected Candida spp. to biomaterials employed as oropharyngeal medical devices. In particular, this study has ominously shown that these materials act as substrates for yeast colonization, highlighting the need for advancements in biomaterial design. Furthermore, it is important that physiological conditions should be employed whenever biocompatibility of oropharyngeal biomaterials is under investigation.
Collapse
Affiliation(s)
- D S Jones
- Medical Devices Unit, School of Pharmacy, The Queen's University of Belfast, Medical Biology center, 97, Lisburn Road, Belfast BT9 7BL, Northern Ireland, United Kingdom
| | | | | | | | | |
Collapse
|
39
|
Jones DS, Garvin CP, Gorman SP. Design of a simulated urethra model for the quantitative assessment of urinary catheter lubricity. J Mater Sci Mater Med 2001; 12:15-21. [PMID: 15348372 DOI: 10.1023/a:1026744732504] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Catheters designed for intermittent urological catheterization should possess appropriate lubricity and mechanical properties to ensure optimal clinical performance. However, the lack of a reproducible in vitro method that simulates clinical use makes it difficult to evaluate the lubricity of urinary catheters and other devices for urethral insertion. Therefore, this study describes a suitable method based on use of a Texture Analyzer to characterize the lubricity of such devices. The novel method was susequently applied to the evaluation of commercially-available intermittent urinary catheters. In addition, other important physicochemical properties of these catheters were examined, namely Young's modulus, degree of hydration and morphology. Catheter lubricity was quantified, using a Texture Analyzer, by measurement of the forces required for insertion and removal of the device from two model substrates, agar and mucin-coated silicone tubing. Significant differences in lubricity were identified between the commercially-available catheters, with Aquacath and Lofric exhibiting the lowest forces of insertion and removal. There were no significant differences between the extent of hydration between the catheters, with the exception of Uro-flo which exhibited the lowest hydration. Therefore, the differences in lubricity were not directly related to the extent of hydration. The forces required for insertion/removal of all catheters were markedly greater in the simulated mucin model than in the agar substrate and the former, simulated urethra model, was accepted to mimic more accurately, the in vivo situation. Significant differences were observed between the Young's Moduli of the catheter biomaterials, with Aquacath possessing the largest value. In conclusion, this study has described the use of a texture analyzer and polymeric substrates for the evaluation of biomaterial lubricity. Using these methods, Aquacath and Lofric catheters exhibited greatest lubricity. However, following additional consideration of the mechanical properties of these biomaterials, Aquacath possessed the most appropriate physicochemical properties for use in intermittent catheterization.
Collapse
Affiliation(s)
- D S Jones
- Medical Devices Unit, School of Pharmacy, The Queen's University of Belfast, Medical Biology Center, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, United Kingdom.
| | | | | |
Collapse
|
40
|
Jones DS. Reversed clock phenomenon: a right-hemisphere syndrome. Neurology 2000; 55:1941. [PMID: 11134411 DOI: 10.1212/wnl.55.12.1939-b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
41
|
McCoy CP, Jones DS, McGovern JG, Gorman SP, Woolfson AD. Determination of the salivary retention of hexetidine in-vivo by high-performance liquid chromatography. J Pharm Pharmacol 2000; 52:1355-9. [PMID: 11186243 DOI: 10.1211/0022357001777504] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
The non-antibiotic antimicrobial agent hexetidine is widely used at a concentration of 0.1% w/v as an oral rinse to reduce the number of viable microorganisms within the oral cavity. However, following use, the available concentration of hexetidine in the oral cavity declines with time, thus compromising the resultant antimicrobial activity. It is, therefore, desirable to determine the persistence of the agent in the oral cavity by quantification of the drug concentration in saliva, thus enabling prediction of its antimicrobial activity in the oral environment. A rapid reverse-phase HPLC method was therefore developed and validated for hexetidine in aqueous solution (Oraldene) and in saliva samples collected from volunteers post-rinsing with 15 mL of hexetidine oral rinse for 30s. The HPLC assay was sufficiently sensitive to accurately detect hexetidine in saliva up to 25 min after in-vivo use of a commercial oral rinse. Furthermore, it was possible to detect hexetidine below the published minimum inhibitory concentrations (MICs) for a selection of microorganisms. From these data a first-order elimination rate constant of hexetidine from the oral cavity was determined post-rinsing in each of six volunteers. The validated HPLC assay method presented is useful for the assay of hexetidine in the oral cavity both at and below MICs. The first-order elimination rate constant shows significant variation between volunteers.
Collapse
Affiliation(s)
- C P McCoy
- School of Pharmacy, The Queen's University of Belfast, Medical Biology Centre, Northern Ireland, UK
| | | | | | | | | |
Collapse
|
42
|
Abstract
In the early 1970s physicians engaged in fierce debates over the most appropriate method of evaluating the efficacy of coronary artery bypass grafting (CABG). With millions of patients and billions of dollars at stake, CABG sparked fierce controversy. Skeptics demanded that randomized controlled trials (RCTs) be performed, while enthusiasts argued that they already had visual proof of CABG's efficacy. When RCTs appeared, they did not settle the controversy. Participants simply reasserted their preconceptions, defending a trial's strengths or exploiting its flaws. The debate centered on standards of knowledge for the evaluation of therapeutic efficacy. Specifically, cardiologists and cardiac surgeons struggled to assess the relevance of different measures of therapeutic success: physiological or clinical, visual or statistical. Many factors contributed to participants' decisions, including disciplinary affiliation, traditions of research, personal experience with angiography, and assessments of the history of cardiac therapeutics. Physicians had to decide whether angiography provided a meaningful representation of the disease and its treatment or whether demonstrations of therapeutic success could come only from long-term statistical evaluation of mortality data.
Collapse
Affiliation(s)
- D S Jones
- Department of the History of Science, Science Center 235, Harvard University, Cambridge, Massachusetts 02138, USA
| |
Collapse
|
43
|
Woolfson AD, Malcolm RK, Campbell K, Jones DS, Russell JA. Rheological, mechanical and membrane penetration properties of novel dual drug systems for percutaneous delivery. J Control Release 2000; 67:395-408. [PMID: 10825570 DOI: 10.1016/s0168-3659(00)00230-3] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
In this study it has been demonstrated that mixtures of two solid drugs, ibuprofen and methyl nicotinate, with different but complementary pharmacological activities and which exist as a single liquid phase over a wide composition range at skin temperature, can be formulated as o/w emulsions without the use of an additional hydrophobic carrier. These novel dual drug systems provided significantly enhanced in vitro penetration rates through a model lipophilic barrier membrane compared to conventional individual formulations of each active. Thus, for ibuprofen, drug penetration flux enhancements of three- and 10-fold were observed when compared to an aqueous ibuprofen suspension and a commercial alcohol-based ibuprofen formulation, respectively. Methyl nicotinate penetration rates were shown to be similar for aqueous gels and emulsified systems. Mechanisms explaining these observations are proposed. Novel dual drug formulations of ibuprofen and methyl nicotinate, formulated within the liquid range at skin temperature, were investigated by oscillatory rheology and texture profile analysis, demonstrating the effects of drug and viscosity enhancer concentrations, and disperse phase type upon the rheological, mechanical and drug penetration properties of these systems.
Collapse
Affiliation(s)
- A D Woolfson
- School of Pharmacy, The Queen's University of Belfast, Medical Biology Centre, 97 Lisburn Road, BT9 7BL, Belfast, UK.
| | | | | | | | | |
Collapse
|
44
|
Jones DS, Woolfson AD, Brown AF, Coulter WA, McClelland C, Irwin CR. Design, characterisation and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J Control Release 2000; 67:357-68. [PMID: 10825567 DOI: 10.1016/s0168-3659(00)00231-5] [Citation(s) in RCA: 127] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
This study describes the formulation, characterisation and preliminary clinical evaluation of mucoadhesive, semi-solid formulations containing hydroxyethylcellulose (HEC, 1-5%, w/w), polyvinylpyrrolidine (PVP, 2 or 3%, w/w), polycarbophil (PC, 1 or 3%, w/w) and tetracycline (5%, w/w, as the hydrochloride). Each formulation was characterised in terms of drug release, hardness, compressibility, adhesiveness (using a texture analyser in texture profile analysis mode), syringeability (using a texture analyser in compression mode) and adhesion to a mucin disc (measured as a detachment force using the texture analyser in tensile mode). The release exponent for the formulations ranged from 0.78+/-0.02 to 1. 27+/-0.07, indicating that drug release was non-diffusion controlled. Increasing the concentrations of each polymeric component significantly increased the time required for 10 and 30% release of the original mass of tetracycline, due to both increased viscosity and, additionally, the unique swelling properties of the formulations. Increasing concentrations of each polymeric component also increased the hardness, compressibility, adhesiveness, syringeability and mucoadhesion of the formulations. The effects on product hardness, compressibility and syringeability may be due to increased product viscosity and, hence, increased resistance to compression. Similarly, the effects of these polymers on adhesiveness/mucoadhesion highlight their mucoadhesive nature and, importantly, the effects of polymer state (particularly PC) on these properties. Thus, in formulations where the neutralisation of PC was maximally suppressed, adhesiveness and mucoadhesion were also maximal. Interestingly, statistical interactions were primarily observed between the effects of HEC and PC on drug release, mechanical and mucoadhesive properties. These were explained by the effects of HEC on the physical state of PC, namely swollen or unswollen. In the preliminary clinical evaluation, a formulation was selected that offered an appropriate balance of the above physical properties and contained 3% HEC, 3% PVP and 1% PC, in addition to tetracycline 5% (as the hydrochloride). The clinical efficacy of this (test) formulation was compared to an identical tetracycline-devoid (control) formulation in nine periodontal pockets (>/=5 mm depth). One week following administration of the test formulation, there was a significant improvement in periodontal health as identified by reduced numbers of sub-gingival microbial pathogens. Therefore, it can be concluded that, when used in combination with mechanical plaque removal, the tetracycline-containing semi-solid systems described in this study would augment such therapy by enhancing the removal of pathogens, thus improving periodontal health.
Collapse
Affiliation(s)
- D S Jones
- School of Pharmacy, The Queen's University of Belfast, Medical Biology Centre, 97, Lisburn Road, BT9 7BL, Northern Ireland, Belfast, UK.
| | | | | | | | | | | |
Collapse
|
45
|
Jones DS, Brown AF, Woolfson AD, Dennis AC, Matchett LJ, Bell SE. Examination of the physical state of chlorhexidine within viscoelastic, bioadhesive semisolids using raman spectroscopy. J Pharm Sci 2000; 89:563-71. [PMID: 10756321 DOI: 10.1002/(sici)1520-6017(200005)89:5<563::aid-jps1>3.0.co;2-q] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
This study examined the effects of polymeric components on the physical state of chlorhexidine within bioadhesive, semisolid formulations using Raman spectroscopy. Semisolid formulations were prepared in which chlorhexidine base (CHX, 5%w/w, particle size <63 microm) was dispersed in aqueous (phosphate-buffered saline, pH 6.8) polymer matrices consisting of one or more polymeric components, namely HEC (3%w/w), PVP (3%), and PC (PC, 3%). Raman spectra were recorded using 785-nm excitation and were typically accumulated for 360 s. The Raman spectra were dominated by the presence of CHX. The spectra of CHX in HEC and in HEC/PVP gels were indistinguishable from that for solid CHX as a result of the insolubility of CHX in these formulations. However, in systems containing PC and CHX, there was a shift in the strongest band from 1564 cm(-1) to 1608 cm(-1), which may be accredited to protonation of the basic CHX by the numerous carboxylic acidic groups on PC. Identical shifts in the band positions were observed when this protonation was modeled using ethanoic acid, supporting the view that there was a simple acid base reaction between PC and CHX. However, there were notable differences in the relative intensities of the peaks from these samples, with the spectrum of CHX in the PC matrix displaying properties intermediate between those of CHX dissolved in ethanoic acid and solid CHX diacetate. This may be accredited to the limited solubility of the CHX-PC ion pair. In matrices containing HEC and PC, no peak was observed at 1564 cm(-1), whereas the intensity of the peak at 1608 cm(-1) was increased. Therefore, in these formulations CHX was completely converted to the di-cation as a result of the synergistic effects of PC (which protonated CHX) and HEC (which solubilized the di-cation). In the absence of either HEC or PC, complete protonation was not achieved. It is suggested that this enhancement of solubility of H(2)CHX(2+) may be due to hydrogen bonding, given the hydroxylated nature of HEC. In conclusion, this study has shown the applicability of Raman spectroscopy for both the analysis of opaque, semisolid formulations and, additionally, for the examination of the state of therapeutic agents within such matrices. In particular, using Raman spectroscopy, it was uniquely possible to identify the roles of various polymeric components on both the ionization and solubilization of CHX within aqueous semisolid systems.
Collapse
Affiliation(s)
- D S Jones
- School of Pharmacy, The Queen's University of Belfast, Medical Biology Centre, 97, Lisburn Road, Belfast BT9 7BL, Northern Ireland, U.K
| | | | | | | | | | | |
Collapse
|
46
|
Andrawis N, Jones DS, Abernethy DR. Aging is associated with endothelial dysfunction in the human forearm vasculature. J Am Geriatr Soc 2000; 48:193-8. [PMID: 10682949] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
Abstract
OBJECTIVE Our objective was to examine the role of the endothelium in maintaining vascular tone in the basal as well as in the contracted state during aging. DESIGN/PARTICIPANTS Responses to brachial artery infusion of acetylcholine in presence and absence of NG-nitro-L-arginine methyl ester (L-NAME) and to angiotensin II were studied in 11 young and 12 old white subjects. MEASUREMENTS Strain gauge plethysmography was used to measure forearm vascular resistance (FVR). The dose of acetylcholine at 50% maximal observed decrease in forearm vascular resistance (EC50) was significantly higher (11.0 +/- 1.59 vs 7.07 +/- .65 microg/min, respectively; mean +/-SEM; P < .05) and the FVR at maximal acetylcholine effect (Emax) remained greater (12.6 +/- 1.75 vs 7.15 +/- 1.25 mm Hg/100 mL tissue volume/min; P < .02) in old compared with young subjects. Acetylcholine effect was significantly reversed by concomitant administration of L-NAME, as indicated by the increase in EC50 (old, 20.2 +/- 3.69; young, 11.9 +/- 1.68 microg/min). RESULTS There was no age-related difference in sodium nitroprusside-induced decrease in FVR. The EC50 and Emax for angiotensin II-mediated increase in FVR were 7.87 +/- 1.15 and 8.36 +/- 1.00 ng/min (EC50) and 5.30 +/- .67 vs 6.56 +/-1.25 mm Hg/100 mL tissue volume/min (Emax), and these were not different in old and young subjects, respectively. CONCLUSIONS These data indicate that aging is associated with impaired endothelial- dependent vascular relaxation and that this is selective, with no age-related change in endothelial-independent vascular relaxation or angiotensin II-mediated vascular contraction.
Collapse
Affiliation(s)
- N Andrawis
- Department of Medicine, Georgetown University Medical Center, Washington, DC, USA
| | | | | |
Collapse
|
47
|
Affiliation(s)
- M M Tunney
- School of Pharmacy, Queen's University of Belfast, United Kingdom
| | | | | |
Collapse
|
48
|
Abstract
BACKGROUND This article describes a carbon dioxide absorbent for use in anesthesia. The absorbent consists of calcium hydroxide with a compatible humectant, namely, calcium chloride. The absorbent mixture does not contain sodium or potassium hydroxide but includes two setting agents (calcium sulphate and polyvinylpyrrolidine) to improve hardness and porosity. METHODS The resultant mixture was formulated and subjected to standardized tests for hardness, porosity, and carbon dioxide absorption. Additionally, the new absorbent was exposed in vitro to sevoflurane, desflurane, isoflurane, and enflurane to determine whether these anesthetics were degraded to either compound A or carbon monoxide. The performance data and inertness of the absorbent were compared with two currently available brands of soda lime: Intersorb (Intersurgical Ltd., Berkshire, United Kingdom) and Dragersorb (Drager, Lubeck, Germany). RESULTS The new carbon dioxide absorbent conformed to United States Pharmacopeia specifications in terms of carbon dioxide absorption, granule hardness, and porosity. When the new material was exposed to sevoflurane (2%) in oxygen at a flow rate of 1 l/min, concentrations of compound A did not increase above those found in the parent drug (1.3-3.3 ppm). In the same experiment, mean +/-SD concentrations of compound A (32.5 +/- 4.5 ppm) were observed when both traditional brands of soda lime were used. After dehydration of the traditional soda limes, immediate exposure to desflurane (60%), enflurane (2%), and isoflurane (2%) produced concentrations of carbon monoxide of 600.0 +/- 10.0 ppm, 580.0 +/- 9.8 ppm, and 620.0 +/-10.1 ppm, respectively. In contrast, concentrations of carbon monoxide were negligible (1-3 ppm) when the anhydrous new absorbent was exposed to the same anesthetics. CONCLUSIONS The new material is an effective carbon dioxide absorbent and is chemically unreactive with sevoflurane, enflurane, isoflurane, and desflurane.
Collapse
Affiliation(s)
- J M Murray
- Department of Anaesthetics and Intensive Care Medicine and the School of Pharmacy, The Queen's University of Belfast, Northern Ireland.
| | | | | | | | | | | |
Collapse
|
49
|
Adair CG, Gorman SP, Feron BM, Byers LM, Jones DS, Goldsmith CE, Moore JE, Kerr JR, Curran MD, Hogg G, Webb CH, McCarthy GJ, Milligan KR. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med 1999; 25:1072-6. [PMID: 10551961 DOI: 10.1007/s001340051014] [Citation(s) in RCA: 287] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE To determine the relationship between, and antibiotic resistance of, endotracheal tube (ET) biofilm and pulmonary pathogens in ventilator-associated pneumonia (VAP). SETTING General intensive care units in two university teaching hospitals. DESIGN The microbiology of ET biofilm and tracheal samples from patients with and without VAP were compared. For individual patients, matching pairs of pathogens were confirmed as identical and characterised for antibiotic susceptibility. PATIENTS 40 intensive care unit patients - 20 with VAP, 20 without VAP as control. The duration of intubation (median and range) was 6.5 days (3-17) and 5 days (2-10), respectively. MEASUREMENTS AND RESULTS Samples of tracheal secretions were taken during ventilation for bacteriological culture. Following extubation, ETs were examined for the presence of biofilm. Isolates of high pathogenic potential included Staphylococcus aureus, enterococci, Enterobacteriaceae, pseudomonads and Candida spp. Where the same microorganism was found on tracheal and ET samples by phenotyping, these were confirmed as identical by genotyping and characterised for antibiotic susceptibility in both the free floating and biofilm forms. Seventy per cent of patients with VAP had identical pathogens isolated from both ET biofilm and tracheal secretions. No pairing of pathogens was observed in control patients (p < 0.005). Susceptibility data for these pairs show that the ET acts as a reservoir for infecting microorganisms which exhibit significantly greater antibiotic resistance than their tracheal counterparts. CONCLUSION This investigation provides further evidence for the role of ET biofilm in VAP. The difficulty in eradicating an established microbial biofilm using antibiotics implies that increased attention must be directed towards modification of the ET to prevent or substantially reduce biofilm formation.
Collapse
Affiliation(s)
- C G Adair
- Northern Ireland Regional Immunogenetics Laboratory
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Abstract
Films containing 20% w/w chlorhexidine base (particle size 63-125 microm) in poly(epsilon-caprolactone), MW 35,000-45,000, were prepared by solvent evaporation and sections attached to the mesio-lingual and mesio-buccal surfaces of the lower first molar in healthy volunteers. Saliva (<1.5 microl) was collected on Periopaper and chlorhexidine concentrations measured by HPLC were typically higher in the area immediately adjacent to the tooth-bonded film sections and lower at more distant sites. Analysis of variance of chlorhexidine concentrations, adjacent to the film sections, showed concentrations were significantly different on the buccal and lingual sides of the tooth and depended on the time of sampling (n=5, P<0.05).
Collapse
Affiliation(s)
- N J Medlicott
- School of Pharmacy, University of Otago, P.O. Box 913, Dunedin, New Zealand.
| | | | | | | | | |
Collapse
|